Back to Authors

Hayden, Kathleen M.

https://orcid.org/0000-0002-7745-3513

A5023816495 | I4405269449

Mayo Clinic

Wake Forest University Health Sciences

Citations 15

P1‐624: SEX‐RELATED DIFFERENCES IN COGNITIVE IMPAIRMENT AMONG OVERWEIGHT AND OBESE ADULTS WITH TYPE 2 DIABETES

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2018.06.637

Sex‐related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes

Alzheimer's & Dementia | July 4, 2018 | Volume: 14 | Issue: 9 | Pages: 1184-1192

10.1016/j.jalz.2018.05.015 | PMID 30201101

AbstractIntroductionType 2 diabetes mellitus and obesity may increase risks for cognitive decline as individuals age. It is unknown whether this results in different prevalences of cognitive impairment for women and men.MethodsThe Action for Health in Diabetes, a randomized controlled clinical trial of a 10‐year intensive lifestyle intervention, adjudicated cases of cross‐sectional cognitive impairment (mild cognitive impairment or dementia) 10–13 years after enrollment in 3802 individuals (61% women).ResultsThe cross‐sectional prevalences of cognitive impairment were 8.3% (women) and 14.8% (men): adjusted odds ratio 0.55, 95% confidence interval [0.43, 0.71], P < .001. Demographic, clinical, and lifestyle risk factors varied between women and men but did not account for this difference, which was limited to individuals without apolipoprotein E (APOE)‐ε4 alleles (interaction P = .034).ConclusionsAmong overweight and obese adults with type 2 diabetes mellitus, traditional risk factors did not account for the lower prevalence of cognitive impairment observed in women compared with men.
New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia

Alzheimer's & Dementia | May 26, 2018 | Volume: 14 | Issue: 6 | Pages: 703-706

10.1016/j.jalz.2018.05.002 | PMID 29842864

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA‐AA Research Framework

Alzheimer's & Dementia | April 10, 2018 | Volume: 14 | Issue: 4 | Pages: 532-534

10.1016/j.jalz.2018.03.003 | PMID 29653605

Hormone therapy and Alzheimer disease dementia

Neurology | October 25, 2012 | Volume: 79 | Issue: 18 | Pages: 1846-1852

10.1212/wnl.0b013e318271f823 | PMID 23100399